In particular, this was found up-regulated in triple-negative breast cancer cells (62) and the regulatory circuit miR-502/H4K20 methyltransferase SET8 was described as a key regulator of breast cancer pathobiology (63). The gene discussed is KMT5A; the disease is triple-negative breast carcinoma.